Search research articles
Contact Us
Filters
Showing results (11-20 of 89) with videos related to
Page
of 9
Sort By:
Cancer Causes & Control : CCC
|
June 8, 2012
Gastrectomy and risk of pancreatic cancer: systematic review and meta-analysis of observational studies
Yuanfeng Gong, Quanbo Zhou, Yu Zhou, et al.
Iscience
|
February 2, 2024
Nudt21-mediated alternative polyadenylation of MZT1 3'UTR contributes to pancreatic cancer progression
Yu Zhou, Jiabin Yang, Leyi Huang, et al.
Molecular Cancer
|
December 5, 2023
Effects of RNA methylation on Tumor angiogenesis and cancer progression
Mingyu Han, Haifeng Sun, Quanbo Zhou, et al.
Cancer Letters
|
April 26, 2025
Tumor-associated Schwann cells as new therapeutic target in non-neurological cancers
Leyi Huang, Ge Qi, Guangyao Chen, et al.
Biomarker Research
|
July 29, 2024
Advances in targeting cancer-associated fibroblasts through single-cell spatial transcriptomic sequencing
Pin Lyu, Xiaoming Gu, Fuqi Wang, et al.
Digestive Surgery
|
September 7, 2013
Expression levels and significance of nuclear factor-κB and epidermal growth factor receptor in hepatolithiasis associated with intrahepatic cholangiocarcinoma
Quanbo Zhou, Yuanfeng Gong, Feng Huang, et al.
Acta Biochimica Et Biophysica Sinica
|
April 1, 2011
Hepatitis C virus core upregulates the methylation status of the RASSF1A promoter through regulation of SMYD3 in hilar cholangiocarcinoma cells
Ning Guo, Rufu Chen, Zhihua Li, et al.
Molecular Therapy. Nucleic Acids
|
March 23, 2022
Exosome-derived noncoding RNAs: Function, mechanism, and application in tumor angiogenesis
Kangkang Yang, Quanbo Zhou, Bingbing Qiao, et al.
Cell Death & Disease
|
March 30, 2021
Cancer-associated fibroblasts-mediated ATF4 expression promotes malignancy and gemcitabine resistance in pancreatic cancer via the TGF-β1/SMAD2/3 pathway and ABCC1 transactivation
Lusheng Wei, Qing Lin, Yanan Lu, et al.
Frontiers in Immunology
|
October 27, 2025
Immunotherapy versus chemotherapy as adjuvant therapy for resected MSI-H/dMMR colorectal cancer: real-world evidence informing precision strategies
Haifeng Sun, Pin Lyu, Shuaixi Yang, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 89) with videos related to
Sort By:
Page
of 9
Cancer Causes & Control : CCC
|
June 8, 2012
Gastrectomy and risk of pancreatic cancer: systematic review and meta-analysis of observational studies
Yuanfeng Gong, Quanbo Zhou, Yu Zhou, et al.
Iscience
|
February 2, 2024
Nudt21-mediated alternative polyadenylation of MZT1 3'UTR contributes to pancreatic cancer progression
Yu Zhou, Jiabin Yang, Leyi Huang, et al.
Molecular Cancer
|
December 5, 2023
Effects of RNA methylation on Tumor angiogenesis and cancer progression
Mingyu Han, Haifeng Sun, Quanbo Zhou, et al.
Cancer Letters
|
April 26, 2025
Tumor-associated Schwann cells as new therapeutic target in non-neurological cancers
Leyi Huang, Ge Qi, Guangyao Chen, et al.
Biomarker Research
|
July 29, 2024
Advances in targeting cancer-associated fibroblasts through single-cell spatial transcriptomic sequencing
Pin Lyu, Xiaoming Gu, Fuqi Wang, et al.
Digestive Surgery
|
September 7, 2013
Expression levels and significance of nuclear factor-κB and epidermal growth factor receptor in hepatolithiasis associated with intrahepatic cholangiocarcinoma
Quanbo Zhou, Yuanfeng Gong, Feng Huang, et al.
Acta Biochimica Et Biophysica Sinica
|
April 1, 2011
Hepatitis C virus core upregulates the methylation status of the RASSF1A promoter through regulation of SMYD3 in hilar cholangiocarcinoma cells
Ning Guo, Rufu Chen, Zhihua Li, et al.
Molecular Therapy. Nucleic Acids
|
March 23, 2022
Exosome-derived noncoding RNAs: Function, mechanism, and application in tumor angiogenesis
Kangkang Yang, Quanbo Zhou, Bingbing Qiao, et al.
Cell Death & Disease
|
March 30, 2021
Cancer-associated fibroblasts-mediated ATF4 expression promotes malignancy and gemcitabine resistance in pancreatic cancer via the TGF-β1/SMAD2/3 pathway and ABCC1 transactivation
Lusheng Wei, Qing Lin, Yanan Lu, et al.
Frontiers in Immunology
|
October 27, 2025
Immunotherapy versus chemotherapy as adjuvant therapy for resected MSI-H/dMMR colorectal cancer: real-world evidence informing precision strategies
Haifeng Sun, Pin Lyu, Shuaixi Yang, et al.
Page
of 9